BioAmber had 60 employees in Sarnia in 2018 when it began a court-supervised liquidation that resulted in the facility’s sale to LCY Biosciences, a subsidiary of Taiwan-based LCY Chemical Corp., for US$4.34 million.
“We’ll be utilizing this time to focus on scaling up,” St. Jean said.